Literature DB >> 2448722

Choroidal neovascularization in degenerative myopia: role of laser photocoagulation.

A E Jalkh1, J J Weiter, C L Trempe, R C Pruett, C L Schepens.   

Abstract

Laser photocoagulation of extrafoveal choroidal new vessels was performed in 19 eyes with degenerative myopia. Sixteen eyes required only one treatment. Three eyes required more than one because of incomplete closure of the new vessels after the first treatment. Choroidal new vessel formation did not recur during the post-treatment follow-up period (average 29.2 months), and a dry, atrophic photocoagulation scar was achieved in all eyes. Visual acuity improved in only two eyes (11%), stabilized in four eyes (21%), and deteriorated in 13 eyes (68%). All except two eyes showed spontaneous progressive enlargement of the atrophic photocoagulation scar, which worsened visual acuity in 13 eyes (68%).

Entities:  

Mesh:

Year:  1987        PMID: 2448722

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  11 in total

1.  Outcome of photodynamic therapy in choroidal neovascularization due to pathologic myopia and related factors.

Authors:  Tugrul Altan; Nur Acar; Ziya Kapran; Yaprak B Unver; Sezin Ozdogan
Journal:  Int Ophthalmol       Date:  2012-02-19       Impact factor: 2.031

Review 2.  Choroidal neovascularisation in pathological myopia: an update in management.

Authors:  W-M Chan; M Ohji; T Y Y Lai; D T L Liu; Y Tano; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

3.  Transpupillary thermotherapy for myopic choroidal neovascularization: 1-year follow-up: TTT for myopic CNV.

Authors:  Sengul Ozdek; Ahmet Hondur; Gokhan Gurelik; Berati Hasanreisoglu
Journal:  Int Ophthalmol       Date:  2006-11-16       Impact factor: 2.031

4.  Radiotherapy for subfoveal neovascularisation associated with pathological myopia: a pilot study.

Authors:  H Kobayashi; K Kobayashi
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

5.  Quantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopia.

Authors:  Ute E K Schnurrbusch; Claudia Jochmann; Peter Wiedemann; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-15       Impact factor: 3.117

Review 6.  Recent trends in the management of maculopathy secondary to pathological myopia.

Authors:  D Mitry; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-13       Impact factor: 3.117

7.  Dissecting the genetics of human high myopia: a molecular biologic approach.

Authors:  Terri L Young
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.

Authors:  D S C Lam; W-M Chan; D T L Liu; D S P Fan; W W Lai; K K L Chong
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

9.  Molecular genetics of human myopia: an update.

Authors:  Terri L Young
Journal:  Optom Vis Sci       Date:  2009-01       Impact factor: 1.973

10.  Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study.

Authors:  C Bruè; A Pazzaglia; C Mariotti; M Reibaldi; A Giovannini
Journal:  Eye (Lond)       Date:  2015-10-30       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.